These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex]. Gamburg AL, Aranovich AG, Kotel'kevich IuN, Omorokov BM, Rasniuk VA. Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169 [Abstract] [Full Text] [Related]
3. [Clinical efficacy of leponex according to the findings of an international study]. Panteleeva GN, Tsutsul'kovskaia MIa, Beliaev BS, Cheshkova E, Pavlovskiĭ P. Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):393-401. PubMed ID: 6144219 [Abstract] [Full Text] [Related]
5. [Own experiences (1989-1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz company]. Abczyńska M, Kaźmirek Z, Syguda J, Termińska K. Psychiatr Pol; 1995; 29(1):79-85. PubMed ID: 7878157 [Abstract] [Full Text] [Related]
9. Clozapine in the treatment of schizophrenic patients: an international multicenter trial. Panteleeva GP, Kovskaya MY, Belyaev BS, Minsker EI, Vynar O, Ceskova E, Svetska J, Libiger J, Korinkova V, Novotny V. Clin Ther; 1987; 10(1):57-68. PubMed ID: 3329966 [Abstract] [Full Text] [Related]